We are live on ! Find out more
CMND icon

Clearmind Medicine
CMND

2 hedge funds and large institutions have $115K invested in Clearmind Medicine in 2023 Q2 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, 1 reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

0.91% more ownership

Funds ownership: 9.03% → 9.94% (+0.91%)

0% more funds holding

Funds holding: 2 → 2 (0)

55% less capital invested

Capital invested by funds: $256K → $115K (-$141K)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
2
Holders Change
–
Holders Change %
0%
% of All Funds
0.03%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
1
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
AI
AdvisorShares Investments
Maryland
-$54K
2
UBS Group
UBS Group
Switzerland
-$3.15K

CMND Hedge Fund Activity: Q2 2023 in Review

2 of the 6,386 institutional investors tracked by Wall St. Rank reported a position in Clearmind Medicine (CMND) for Q2 2023, worth a combined $115K — down 55% from $256K a quarter earlier.

Fund positioning in CMND was balanced in Q2 2023: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 1 trimmed.

The largest seller was AdvisorShares Investments, cutting an estimated $54K.

  • 2 institutional investors held Clearmind Medicine (CMND) as of Q2 2023, unchanged from Q1 2023.
  • Funds reported $115K of Clearmind Medicine stock for Q2 2023, down 55% quarter-over-quarter.
  • 0 funds opened new Clearmind Medicine positions in Q2 2023 and 0 closed out.
  • The largest Clearmind Medicine seller in Q2 2023 was AdvisorShares Investments, an estimated $54K sold.

Based on aggregated 13F filings for Q2 2023.